You are currently viewing a new version of our website. To view the old version click .

Most Recent

  • Systematic Review
  • Open Access

Intestinal-Type Adenocarcinoma Is a Rare Histotype of Vulvar Neoplasm: Systematic Review of the Literature

  • Alessio Colalillo,
  • Dominga Boccia,
  • Luigi Della Corte,
  • Daniele Neola,
  • Federica Rosato,
  • Silvia D’Ippolito,
  • Maria De Ninno,
  • Damiano Arciuolo,
  • Maurizio Guida and
  • Giuseppe Bifulco
  • + 1 author
Cancers2025, 17(24), 3989;https://doi.org/10.3390/cancers17243989 
(registering DOI)

14 December 2025

Background: Intestinal-type vulvar adenocarcinoma (VAIt) is an exceptionally rare form of primary vulvar cancer, characterized by histological features resembling mucinous colonic carcinomas, including villo-glandular structures composed of goblet an...

  • Review
  • Open Access

Refining Surgical Standards: The Role of Robotic-Assisted Segmentectomy in Early-Stage Non-Small-Cell Lung Cancer

  • Masaya Nishino,
  • Hideki Ujiie,
  • Masaoki Ito,
  • Hana Oiki,
  • Shota Fukuda,
  • Mai Nishina,
  • Shuta Ohara,
  • Akira Hamada,
  • Masato Chiba and
  • Toshiki Takemoto
  • + 1 author
Cancers2025, 17(24), 3988;https://doi.org/10.3390/cancers17243988 
(registering DOI)

14 December 2025

Background: Recent trials, including JCOG0802/WJOG4607L and CALGB140503, have confirmed the oncological adequacy of segmentectomy for early-stage non-small-cell lung cancer (NSCLC). This shift emphasizes the preservation of pulmonary function and min...

  • Review
  • Open Access
Cancers2025, 17(24), 3987;https://doi.org/10.3390/cancers17243987 
(registering DOI)

14 December 2025

HER2 (human epidermal growth factor receptor 2) is a receptor tyrosine kinase which is overexpressed in ~20% of patients with oesophagogastric adenocarcinoma (EGA). HER2 represents a targetable transmembrane glycoprotein receptor of the epidermal gro...

  • Article
  • Open Access

Perioperative Chemotherapy in Bladder and Upper Tract Urothelial Carcinoma: Outcomes by Nodal Status and Lymphovascular Invasion

  • Nobuki Furubayashi,
  • Jiro Tsujita,
  • Azusa Takayama,
  • Yuta Shiraishi,
  • Motonobu Nakamura and
  • Takahito Negishi
Cancers2025, 17(24), 3986;https://doi.org/10.3390/cancers17243986 
(registering DOI)

14 December 2025

Background/Objectives: Optimal selection for perioperative therapy in urothelial carcinoma (UC) remains uncertain. We evaluated the efficacy of neoadjuvant and/or adjuvant chemotherapy (NAC/AC) for patients with bladder cancer (BC) and upper tract UC...

  • Review
  • Open Access

Artificial Intelligence and Machine Learning in Lung Cancer: Advances in Imaging, Detection, and Prognosis

  • Mohammad Farhan Arshad,
  • Adiba Tabassum Chowdhury,
  • Zain Sharif,
  • Md. Sakib Bin Islam,
  • Md. Shaheenur Islam Sumon,
  • Amshiya Mohammedkasim,
  • Muhammad E. H. Chowdhury and
  • Shona Pedersen
Cancers2025, 17(24), 3985;https://doi.org/10.3390/cancers17243985 
(registering DOI)

14 December 2025

Background/Objectives: As the primary cause of cancer-related death globally, lung cancer highlights the critical need for early identification, precise staging, and individualized treatment planning. By enabling automated diagnosis, staging, and pro...

  • Review
  • Open Access

Can TP53, TMB and TME Expand the Immunotherapy Benefit in Metastatic Colorectal Cancer?

  • Monia Specchia,
  • Denise Drittone,
  • Eva Mazzotti and
  • Federica Mazzuca
Cancers2025, 17(24), 3984;https://doi.org/10.3390/cancers17243984 
(registering DOI)

13 December 2025

Background: Metastatic colorectal cancer (mCRC) with TP53 gene mutations, which are commonly found in tumors that are microsatellite stable (MSS) and not prone to genetic errors seen in some cancers, is associated with aggressive cancer behavior and...

  • Article
  • Open Access

Epithelioid Mesothelioma Cells Exhibit Increased Ferroptosis Sensitivity Compared to Non-Epithelioid Mesothelioma Cells

  • Tatsuhiro Sato,
  • Ikue Hasegawa,
  • Haruna Ikeda,
  • Taichi Ohshiro,
  • Lisa Kondo-Ida,
  • Satomi Mukai,
  • Satoshi Ohte,
  • Tohru Maeda and
  • Yoshitaka Sekido
Cancers2025, 17(24), 3983;https://doi.org/10.3390/cancers17243983 
(registering DOI)

13 December 2025

Background/Objectives: Mesothelioma is a highly aggressive tumor with a poor prognosis that typically develops after a long latency period following asbestos exposure. Although immunotherapy combined with chemotherapy is increasingly used, the effica...

  • Review
  • Open Access

Gaps in Diagnosis, Treatment, and Outcomes Among Patients with Brain Tumors in the United States: A State-of-the-Art Review

  • Vivek Podder,
  • Zouina Sarfraz,
  • Khalid Ahmad Qidwai,
  • Arun Maharaj,
  • Tulika Ranjan,
  • Sonikpreet Aulakh and
  • Manmeet S. Ahluwalia
Cancers2025, 17(24), 3982;https://doi.org/10.3390/cancers17243982 
(registering DOI)

13 December 2025

Brain tumors, both malignant and non-malignant, represent a persistent global health challenge. Differences in diagnosis, treatment, and outcomes are influenced by race, ethnicity, socioeconomic status (SES), and geographical location. Brain and cent...

  • Review
  • Open Access

Lynch Syndrome in Focus: A Multidisciplinary Review of Cancer Risk, Clinical Management, and Special Populations

  • Seyma Eroglu,
  • Ilhan Birsenogul,
  • Alexandra P. Bowen,
  • Joseph F. Doyle,
  • Stephen E. Pupkin,
  • Joaquin Villar,
  • Christopher M. Tarney,
  • Edwin Gandia,
  • Danielle M. Pastor and
  • Juvianee I. Estrada-Veras
Cancers2025, 17(24), 3981;https://doi.org/10.3390/cancers17243981 
(registering DOI)

13 December 2025

Lynch syndrome (LS), also known as hereditary nonpolyposis colorectal cancer (HNPCC), is a hereditary cancer syndrome significantly increasing the risk of colorectal cancer (CRC) and various extracolonic cancers, including endometrial, ovarian, and g...

  • Article
  • Open Access

A Real-World Experience on the Efficacy of First-Line Treatment with Immune-Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Patients with PD-L1 Expression ≥50%: The Role of KRAS Mutations

  • Lucia Motta,
  • Samantha Epistolio,
  • Jana Pankovics,
  • Francesca Molinari,
  • Benjamin Pedrazzini,
  • Alexandra Valera,
  • Luca Giudici,
  • Stefania Freguia,
  • Miriam Patella and
  • Martina Imbimbo
  • + 3 authors
Cancers2025, 17(24), 3980;https://doi.org/10.3390/cancers17243980 
(registering DOI)

13 December 2025

Background/Objectives: Several genetic alterations have been identified as drivers of uncontrolled cell growth in lung cancer, with KRAS mutations representing the most prevalent driver oncogene. Despite advances in targeted treatment, the 5-year sur...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694